Latest in Pharmaceutical

ESTEVE CDMO invests $80m in new China API manufacturing site

The Shaoxing facility will provide 250 m³ of reaction volume, with potential capacity exceeding 400 m³, as the CDMO expands its global small-molecule API manufacturing network

Find out more
ESTEVE CDMO invests $80m in new China API manufacturing site

Clinisys unveils governed AI roadmap for connected laboratories

Clinisys unveils governed AI roadmap for connected laboratories

Connected Laboratory Intelligence links trusted data, analytics, agents and automation to help laboratories move from insight to action
See more
Ardena invests in tablet compaction technology to accelerate OSD drug development

Ardena invests in tablet compaction technology to accelerate OSD drug development

The CDMO has installed a KORSCH STYL’ONE Evo compaction simulator at its Ghent, Belgium, headquarters to reduce material use and support faster oral solid dose scale-up
Eppendorf expands BioLabs partnership to support biotech startups in Munich

Eppendorf expands BioLabs partnership to support biotech startups in Munich

Eppendorf has extended its collaboration with BioLabs to the new BioLabs | TUM site in Munich, providing resident biotech companies with laboratory equipment, technical support, training and opportunities to engage with life-science experts
Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

The UK biotech's Doggybone DNA platform won the Innovation Catalyst category at CPHI Milan 2026, recognising its potential to support scalable DNA production for genetic medicines
Agilent expands Boulder facility with dedicated enzymatic ligation laboratory for oligonucleotide therapeutics

Agilent expands Boulder facility with dedicated enzymatic ligation laboratory for oligonucleotide therapeutics

The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approaches as oligonucleotide pipeline demand grows
Biosynth expands complex chemistry portfolio for biologics and vaccines

Biosynth expands complex chemistry portfolio for biologics and vaccines

The expansion includes new fluorinated sugars and GMP-grade Poly(I:C), supporting glycoengineering, bioproduction, vaccine and immunotherapy development
FUJIFILM Biotechnologies lands three CPHI Pharma Award nominations for continuous manufacturing and precision purification

FUJIFILM Biotechnologies lands three CPHI Pharma Award nominations for continuous manufacturing and precision purification

The CDMO's MaruX platform, ShunzymeX purification technology and COO Maja Pedersen are all shortlisted ahead of its CPHI Milan appearance at booth 8A2, where senior leadership will present on Europe's biomanufacturing strategy
GLP-1 news round-up: what's happened in weight loss

GLP-1 news round-up: what's happened in weight loss

Lilly's retatrutide posts strong Phase III results, Novo Nordisk pays up to $2.6bn for an oral candidate and nasal and AI-designed approaches advance
From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

By integrating GEA granulation technology into its new facility, Beta Pharmacon has enhanced process control, reinforced its commitment to regulatory compliance, and secured GMP and USP qualifications to supply essential micronutrient supplements

Latest posts in Pharmaceutical

Nanexa signs €1.165bn Novo deal for long-acting injectable technology

Nanexa signs €1.165bn Novo deal for long-acting injectable technology

The Swedish drug delivery company has granted Novo a global licence to its PharmaShell atomic layer deposition platform for long-acting peptide medicines targeting obesity, type 2 diabetes and other cardiometabolic diseases
Recipharm and CanVirex partner on scalable oncolytic virus manufacturing

Recipharm and CanVirex partner on scalable oncolytic virus manufacturing

Recipharm will develop a scalable Vero cell/measles virus manufacturing process for CanVirex’s IL-12-expressing oncolytic virus platform targeting advanced solid tumours
From classroom to cleanroom: how a teacher built Ireland's pioneering dronabinol pharma company

From classroom to cleanroom: how a teacher built Ireland's pioneering dronabinol pharma company

Dunbar Pharma CEO Leah Fletcher talks to Emily Letton at Manufacturing Chemist about regulatory hurdles, the chemistry of cannabinoid API and why plant-derived dronabinol beats synthetic
Shilpa Medicare launches dedicated Shilpa CDMO for complex small molecules ahead of CPHI Milan

Shilpa Medicare launches dedicated Shilpa CDMO for complex small molecules ahead of CPHI Milan

The standalone entity brings 230 kL reactor capacity, 400+ scientists and specialist teams for HPAPIs, PROTACs, oligonucleotides and ADC payloads — with proximity to Shilpa Biologicals enabling integrated ADC development within a 200-mile supply chain
CPHI Milan Pharma Awards finalists revealed for 2026

CPHI Milan Pharma Awards finalists revealed for 2026

This year's finalists for the CPHI Pharma Awards have been decided from hundreds of entries received across 15 categories, showcasing companies, technologies and individuals making an impact in pharma
Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal

Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal

Hanmi Pharm has granted Genentech global rights to develop and commercialise HM17321, an investigational UCN2 analogue designed to drive weight loss while preserving lean mass
Irish manufacturer brings EU GMP-certified dronabinol API to UK specials market

Irish manufacturer brings EU GMP-certified dronabinol API to UK specials market

Dunbar Pharmaceuticals partners with IPS Pharma to supply plant-derived dronabinol API for UK Specials-pathway cannabis medicines, following its earlier expansion into Germany
You need to be a subscriber to read this article.
Click here to find out more.
Henlius and Sandoz expand global biosimilars partnership with up to ten assets

Henlius and Sandoz expand global biosimilars partnership with up to ten assets

Shanghai Henlius and Sandoz have expanded their existing partnership to cover up to ten monoclonal antibody and antibody-drug conjugate biosimilars, with an initial deal potentially worth up to $322m
Panthera opens clinical research site at Keele University

Panthera opens clinical research site at Keele University

Panthera has opened a new clinical trial site at Keele University, expanding its UK and European research network to 11 locations and increasing access to clinical studies in Staffordshire
Androlabs appoints EffRx as Swiss commercial partner for testosterone therapy Testavan

Androlabs appoints EffRx as Swiss commercial partner for testosterone therapy Testavan

The agreement expands Testavan's European commercial footprint, giving EffRx distribution rights in Switzerland as Androlabs targets an underdiagnosed hypogonadism market affecting an estimated 10-40% of men globally
AstronauTx secures rights to Saniona neurological drug candidate

AstronauTx secures rights to Saniona neurological drug candidate

The firm has exercised its option to acquire worldwide rights to ATX0926 from Saniona, moving the sleep biology-focused small molecule into IND-enabling development

Sponsor Promoted Content

Beyond the Vacuum Pump: Is your Vacuum System costing more than you think?

Beyond the Vacuum Pump: Is your Vacuum System costing more than you think?

Many facilities continue to rely on oil-lubricated vacuum pumps that were installed years ago. The question is no longer whether these pumps work. The question is whether...
Lonza upgrades organic growth model and mid-term financial ambitions at capital Markets Day; Q3 2026 in line with expectations

Lonza upgrades organic growth model and mid-term financial ambitions at capital Markets Day; Q3 2026 in line with expectations

At its Capital Markets Day in Vacaville, California, Lonza reports progress of its One Lonza Strategy to deliver long-term, profitable, above-market growth
From scattered machine data to smarter production decisions

From scattered machine data to smarter production decisions

GEA's digital tools are being developed to help pharmaceutical production and maintenance teams bring equipment information, service support and performance data closer...
The importance of nitrosamines and recent developments in analysis

The importance of nitrosamines and recent developments in analysis

Nitrosamines are substances with an N=O (N-nitroso) functional group, and toxicologists consider them to be highly toxic
Systech launches new all-in-one pharma packaging and serialisation stations

Systech launches new all-in-one pharma packaging and serialisation stations

New integrated solutions help pharmaceutical manufacturers and CDMOs increase automation, improve efficiency, and streamline packaging operations
Containment at scale: Safer filtration and drying of high-potency APIs

Containment at scale: Safer filtration and drying of high-potency APIs

High-potency APIs demand robust containment during filtration and drying. Integrated, closed systems can reduce operator exposure, eliminate material handling and deliver...
How CDMOs can scale microsphere production with one flexible platform

How CDMOs can scale microsphere production with one flexible platform

Interchangeable mesh technology lets CDMOs process diverse microsphere formulations on one refiner platform, reducing capital costs, changeover time and scale-up risk...
Xelia and Hisun sign strategic global multiple-API partnership

Xelia and Hisun sign strategic global multiple-API partnership

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology
Piramal Pharma receives Ontario investment for API site

Piramal Pharma receives Ontario investment for API site

Piramal Pharma Solutions (PPS) is to invest more than $5.3m in upgrading its drug substance manufacturing site in Aurora, Canada, supported by a $1.75m investment from the...
Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month

Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month

Piramal Pharma Solutions (“PPS”), a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Piramal Pharma Ltd. (“PPL”) (NSE:...
Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development

Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development

New AI-enhanced solution helps identify promising drug formulations, compressing early clinical decision-making for new treatments
AI in quality: Why human judgment still matters in an automated world

AI in quality: Why human judgment still matters in an automated world

Explore the rise of AI in pharmaceutical quality and the risks of over-reliance, examining why experience, instinct and critical thinking remain essential to sound...

Featured companies

Edwards Vacuum is one of the global leaders in vacuum and abatement solutions, with more than 100 years of engineering expertise supporting industries worldwide. For chemical,... Atlas Copco provides advanced pharmaceutical manufacturing solutions that support compliance, efficiency and quality in global drug production. Its offering includes oil-free... 3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support...
See more